RT Journal Article
T1 Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
A1 Sánchez Guijo, Fermín
A1 Avendaño Solá, Cristina
A1 Badimón, Lina
A1 Bueren, Juan
A1 Canals, Josep
A1 Delgadillo, Joaquim
A1 Delgado, Julio
A1 Eguizábal, Cristina
A1 Fernández Santos, María Eugenia
A1 García Olmo, Damián
A1 González Aseguinolaza, Gloria
A1 Juan, Manel
A1 Martín, Francisco
A1 Mata, Rosario
A1 Montserrat, Nuria
A1 Pérez Martínez, Antonio
A1 Pérez Simón, José
A1 Prósper, Felipe
A1 Urbano Ispizua, Álvaro
A1 Zapata González, Agustín Gregorio
A1 Sureda, Anna
A1 Moraleda, José
AB The Hospital Exemption rule is considered a valuable European legislative initiative that guarantees patient access to novel therapies based on the use of advanced therapy medicinal products (ATMPs) in the Member States. On the occasion of the update of the European General Pharmaceutical Legislation, the Spanish Network of Advanced Therapies (TERAV, formerly TerCel), which has played a recognized leadership in Europe in the development of both academic and pharmaceutically commercialized ATMPs, would like to make the following position statement.
PB Springer Nature
SN 0268-3369
YR 2023
FD 2023
LK https://hdl.handle.net/20.500.14352/88626
UL https://hdl.handle.net/20.500.14352/88626
LA eng
NO Sánchez-Guijo, Fermín, et al. «Role of Hospital Exemption in Europe: Position Paper from the Spanish Advanced Therapy Network (TERAV)». Bone Marrow Transplantation, vol. 58, n.o 6, junio de 2023, pp. 727-28. https://doi.org/10.1038/s41409-023-01962-0.
DS Docta Complutense
RD 9 abr 2025